As AI enters healthcare, why docs and regulators grapple with safety and oversight
As AI enters healthcare, why docs and regulators grapple with safety and oversight is drawing significant interest across the industry.
AI can spot diseases early and cut costs but transparency gaps, data bias and slow clinical trials raise serious concerns
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Kakao, Google Form AI Strategic Partnership
- How a viral social media site for AI bots is suffering a human problem
- Pakistan declares ‘open war’ against Afghanistan, kills 150 Taliban fighters under Operation Ghazab lil Haq
- Oil slides on Iran nuclear talks, fresh US tariff uncertainty
Source: Original →